Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- CheckyesterdayChange DetectedAdded a Locations section listing study sites by state across the United States (Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin) and Revision: v3.3.3. Removed the previous per-state location blocks and the HHS Vulnerability Disclosure entry in this revision.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded UF Health Cancer Institute - Gainesville as a study site (2025-12-02) and removed University of Florida Health Science Center - Gainesville (2025-09-18/19).SummaryDifference0.1%

- Check23 days agoChange DetectedComparing the screenshots shows no changes to core study details (title, conditions, objectives, eligibility, or locations); observed differences seem limited to layout and formatting. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedTwo small textual changes were made: the PubMed publications line was reworded to say publications are automatically filled in from PubMed, and the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding status notice banner was removed.SummaryDifference0.2%

- Check44 days agoChange DetectedNo substantive changes detected in the NCT02867592 Study Details page; the differences appear to be cosmetic styling or layout adjustments and do not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.